# Rectal Study: Value of Repeated FDG-PET-CT Scans in Rectal Cancer

> **NCT00576563** · NA · COMPLETED · sponsor: **Maastricht Radiation Oncology** · enrollment: 103 (actual)

## Conditions studied

- Rectum Cancer

## Interventions

- **DRUG:** FDG

## Key facts

- **NCT ID:** NCT00576563
- **Lead sponsor:** Maastricht Radiation Oncology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2015-01
- **Final completion:** 2015-12
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2016-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00576563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00576563, "Rectal Study: Value of Repeated FDG-PET-CT Scans in Rectal Cancer". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00576563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*